サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1606557

スマートポンプの世界市場-2024～2031年

Global Smart Pumps Market - 2024-2031

出版日
ページ情報
英文 179 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.06円
スマートポンプの世界市場-2024～2031年
出版日: 2024年12月04日
発行: DataM Intelligence
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

スマートポンプの世界市場は2023年に94億米ドルに達し、2031年には167億米ドルに達すると予測され、予測期間2024年にはCAGR 7.5%で成長する見込みです。

スマートポンプは、静脈内（IV）、経腸、またはその他の送達ルートを通じて患者に正確かつ安全に輸液、投薬、または栄養剤を送達するように設計された技術的に先進的医療機器です。これらのポンプはインテリジェントなソフトウェア、センサー、接続機能を統合し、精度を高め、エラーを減らし、患者ケアを最適化します。医療におけるスマートポンプは、医療技術における重要な進歩であり、重要な治療法の正確で安全かつ効率的な送達を可能にします。

医療におけるスマートポンプ市場は急速に拡大しています。この成長の原動力となっているのは、投与ミス削減ソフトウェアやスマート統合機能といった患者安全機能に対する需要の高まりです。例えば、米国国立衛生研究所（National Institute of Health）によると、米国医療システム薬剤師協会（ASHP）が作成した調査によると、米国の病院の89.5％がスマートポンプ技術を使用しています。スマートポンプ技術の利用率は病院のベッドサイズによって異なり、600床以上の病院では完全に導入されていました。

さらに、米国国立衛生研究所が実施した研究によると、スマートポンプの記録を用いて、レベルIVのNICUに入院している新生児と乳児に使用された連続注入薬の37万件以上の注入開始が評価されました。スマートポンプは、最大投与量の7～29倍という高用量のハード上限を超える160回の試行を防止し、ソフト上限の警告後に2093回の輸液の再プログラミングまたはキャンセルをもたらしました。

市場力学：

促進要因と阻害要因

在宅医療需要の増加

在宅医療に対する需要の高まりは、スマートポンプ市場の成長を大きく後押ししており、病院以外の場所でも使用できる信頼性が高く正確で遠隔管理可能な医療機器に対するニーズを高めることで、予測期間中も市場を牽引していくとみられます。世界人口の高齢化に伴い、糖尿病、心臓病、腎不全などの慢性疾患の有病率が高まっています。これらの疾患では、輸液ポンプによるインスリン投与、非経口栄養、疼痛管理など、長期にわたる治療が必要となることが多いです。正確な投与とリアルタイムのモニタリングが可能なスマートポンプは、家庭での使用に理想的です。

世界保健機関（WHO）によると、世界で約8億3,000万人が糖尿病を患っており、その大半は中低所得国に住んでいます。糖尿病患者数は1990年の2億人から2022年には8億3,000万人に増加しています。2021年には、糖尿病と糖尿病による腎臓病で200万人以上が死亡しています。また、心血管疾患による死亡の約11％は高血糖が原因です。このような糖尿病の増加は、インスリンポンプの需要を増加させる可能性があるため、家庭で使用するスマートポンプの需要が増加しています。

例えば、国立衛生研究所によると、22ヶ月間でインスリンポンプの使用率は45％から58％に増加し、大幅に改善しました。インスリンポンプを含む糖尿病技術の使用は、特に青少年の1型糖尿病における血糖コントロールの改善と関連しています。これにより、家庭でのインスリン量管理に役立つスマートポンプの需要がさらに高まっています。

スマートポンプの普及に拍車をかけているのが、患者中心のケアや在宅入院プログラムの動向です。医療プロバイダーは、患者が自宅で治療を管理できるようにすることで、病院への通院を減らし、コストを削減する傾向が強まっています。例えば、化学療法や在宅非経口栄養療法、持続的インスリン療法を受けている患者は、スマートポンプを使用することで、医療専門家が遠隔モニタリングしながら安全に治療を行うことができます。

例えば、メディケア＆メディケイドサービスセンター（CMS）アクチュアリー部の分析によると、米国では在宅医療に1,030億米ドル近くが費やされ、この数字は2026年までに1,730億米ドル近くに達するといいます。この成長の背景には、外来診療の推進、医療コストの増加、在宅医療機器の改良があります。

運用とユーザーの課題

スマートポンプ市場の成長を妨げる要因として、運用面やユーザー側の課題が予想されます。スマートポンプの先進的機能や大きなメリットにもかかわらず、これらの課題は、特に病院、クリニック、在宅環境などの複雑な医療環境での普及を妨げています。スマートポンプには、投与エラー削減ソフトウェア、遠隔モニタリング、病院システムとの統合といった先進的機能が搭載されています。これらの機能を効果的に操作するには、より先進的技術的知識が必要となります。例えば、化学療法やインスリンのようなドラッグデリバリー用に設計されたポンプは、複雑な設定が可能であるため、十分なトレーニングを受けていない医療従事者を圧倒する可能性があります。

さらに、病院では、特に従来のポンプから切り替えた場合、スマートポンプの取り扱いを習得するのに時間がかかると報告する医療スタッフもいます。このため、最初の移行期間中にヒューマンエラーが発生する可能性が高くなり、施設がスマートポンプ技術を完全に採用する意欲をなくす可能性があります。

場合によっては、病院はスマート輸液ポンプと投薬管理システムとの統合の課題に直面しています。機器やシステム間で標準化されたプロトコルがないため、これらの機器を既存のインフラに接続するには時間とコストがかかります。例えば、ユニバーシティ・ヘルスシステム（UHS）によると、スマートポンプは1,200～1,300ドルかかります。1回のセットアップにかかる費用は、ソフトウェアのライセンス費用を含めて、通常3,000ドルから4,000ドル程度です。7,000台のIVポンプの在庫のうち、UHSには約1,800～2,400台のスマートポンプがありました。

目次

第1章 市場イントロダクションと範囲

  • 報告書の目的
  • 調査範囲と定義
  • 調査範囲

第2章 エグゼクティブ洞察と主要ポイント

  • 市場のハイライトと戦略的ポイント
  • 主要動向と将来の予測
  • 製品タイプ別のスニペット
  • 接続性によるスニペット
  • 用途別スニペット
  • エンドユーザーによる抜粋
  • 地域別スニペット

第3章 市場力学

  • 影響要因
    • 促進要因
      • 在宅医療の需要の高まり
      • 技術の進歩の高まり
    • 抑制要因
      • 運用とユーザーの課題
    • 機会
    • 影響分析

第4章 戦略的洞察と産業展望

  • 市場のリーダーと先駆者
    • 新たな先駆者と著名な参入企業
    • 最大の売上を誇るブランドを持つ確立されたリーダー
    • 確立された製品を持つ市場リーダー
  • 新興スタートアップ企業と主要イノベーター
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格市場力学

第5章 スマートポンプ市場、製品タイプ別

  • インフュージョンポンプ
  • スマート給餌ポンプ
  • 特殊ポンプ

第6章 スマートポンプ市場、接続性別

  • スタンドアロンポンプ
  • 接続ポンプ
    • 有線接続
    • ワイヤレス接続

第7章 スマートポンプ市場、用途別

  • ドラッグデリバリー
  • 化学療法
  • 疼痛管理
  • 糖尿病管理
  • 新生児・小児ケア
  • その他

第8章 スマートポンプ市場、エンドユーザー別

  • 病院
  • 専門クリニック
  • 外来手術センター
  • 在宅医療

第9章 スマートポンプ市場、地域別市場分析と成長機会

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋
  • 中東・アフリカ

第10章 競合情勢と市場ポジショニング

  • 競合状況概要と主要な市場参入企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併、買収
  • 製品ポートフォリオとイノベーションにおける主要開発
  • 企業ベンチマーク

第11章 企業プロファイル

  • B. Braun Medical Inc.
  • SWOT分析
  • Medtronic plc
  • Fresenius Kabi USA, LLC
  • Terumo Corporation
  • Becton, Dickinson and Company
  • ICU Medical, Inc.
  • Baxter International Inc.
  • Insulet Corporation
  • BPL Medical Technologies
  • SINO MDT（この一覧に記載されている企業は一部のみとなります。）

第12章 仮定と調査手法

  • データ収集方法
  • データの三角測量
  • 予測技術
  • データの検証と検証

第13章 付録

目次
Product Code: MD8861

Overview

The global smart pumps market reached US$ 9.4 billion in 2023 and is expected to reach US$ 16.7 billion by 2031, growing at a CAGR of 7.5% during the forecast period 2024-2031.

Smart pumps are technologically advanced medical devices designed to accurately and safely deliver fluids, medications or nutrients to patients through intravenous (IV), enteral or other delivery routes. These pumps integrate intelligent software, sensors and connectivity features to enhance precision, reduce errors and optimize patient care. Smart pumps in healthcare represent a significant advancement in medical technology, enabling precise, safe and efficient delivery of critical therapies, with applications ranging from critical care units to home healthcare environments.

The smart pump market in healthcare is expanding rapidly. This growth is fueled by increased demand for patient safety features like dose error reduction software and smart integration capabilities. For instance, according to the National Institute of Health, 89.5% of hospitals in the United States used smart pump technology according to a survey developed by the American Society of Health-System Pharmacists (ASHP). The utilization of smart pump technology varied by hospital bed size with full implementation in hospitals with 600 beds and more.

Additionally, according to the study conducted by the National Institute of Health, using smart pump records, over 370,000 infusion starts for continuously infused medications used in neonates and infants hospitalized in a level IV NICU were evaluated. Smart pumps prevented 160 attempts to exceed the hard maximum limit for doses that were as high as 7-29 times the maximum dose and resulted in the reprogramming or cancellation of 2093 infusions after soft maximum alerts.

Market Dynamics: Drivers & Restraints

Rising demand for home healthcare

Rising demand for home healthcare is significantly driving the growth of the smart pumps market and is expected to drive the market over the forecast period by increasing the need for reliable, accurate and remotely manageable medical devices that can be used outside of hospital settings. As the global population ages, there is a higher prevalence of chronic conditions such as diabetes, heart disease and kidney failure. These conditions often require long-term treatments such as insulin delivery, parenteral nutrition and pain management through infusion pumps. Smart pumps, with their ability to provide accurate dosing and real-time monitoring, are ideal for home use.

According to the World Health Organization, about 830 million people worldwide have diabetes, the majority living in low-and middle-income countries. The number of people living with diabetes rose from 200 million in 1990 to 830 million in 2022. In 2021, diabetes and kidney disease due to diabetes caused over 2 million deaths. In addition, around 11% of cardiovascular deaths were caused by high blood glucose. This rising diabetes may increase the demand for insulin pumps, thus, there is an increasing demand for smart pumps to use at home.

For instance, according to the National Institute of Health, over 22 months, insulin pump use rates increased from 45 to 58%, a significant improvement. Use of diabetes technology, including insulin pumps, has been associated with improved glycemic control, particularly in youths with type 1 diabetes. This further increases the demand for smart pumps which helps to manage insulin levels at home.

The trend toward patient-centric care and hospital-at-home programs is fueling the adoption of smart pumps. Healthcare providers are increasingly allowing patients to manage their treatments at home, reducing hospital visits and costs. For instance, patients receiving chemotherapy, home parenteral nutrition or continuous insulin therapy can use smart pumps to safely administer their treatments while being monitored remotely by healthcare professionals.

For instance, almost $103 billion was spent on home health care in the United States and that number will reach nearly $173 billion by 2026, according to an analysis from the Centers for Medicare & Medicaid Services (CMS) Office of the Actuary. This growth is driven by the push for outpatient care, increasing healthcare costs and improvements in home-based medical devices.

Operational and user challenges

Operational and user challenges are expected to hamper the growth of the smart pumps market. Despite their advanced features and significant benefits, these challenges hinder widespread adoption, particularly in complex healthcare environments like hospitals, clinics, and home settings. Smart pumps come with sophisticated features like dose error reduction software, remote monitoring and integration with hospital systems. These features require a higher level of technical knowledge to operate effectively. For instance, pumps designed for drug delivery, such as those for chemotherapy or insulin, may have intricate settings that can overwhelm healthcare professionals without adequate training.

Additionally, in hospitals, some medical staff report a steep learning curve when it comes to handling smart pumps, especially when switching from traditional pumps. This increases the likelihood of human errors during the initial transition period, which can discourage facilities from fully adopting smart pump technologies.

In some instances, hospitals have faced integration challenges with their smart infusion pumps and medication administration systems. The lack of standardized protocols across devices and systems means that connecting these devices with existing infrastructure can be time-consuming and costly. For instance, according to the University Health System (UHS), smart pumps can run $1,200 to $1,300. One setup typically falls within a cost range of $3,000 to $4,000, including the software license cost. Of the 7,000 IV pumps in inventory, UHS had about 1,800 to 2,400 smart pumps.

Segment Analysis

The global smart pumps market is segmented based on product type, connectivity, application, end-user and region.

Product Type:

The infusion smart pumps segment is expected to dominate the smart pumps market share

The infusion smart pumps segment is expected to dominate the global smart pumps market. Infusion pumps are used extensively across various healthcare settings, including hospitals, clinics and home care environments. These devices are essential for drug delivery, parenteral nutrition, chemotherapy and insulin therapy, among other treatments.

Infusion smart pumps incorporate advanced dose error reduction systems, wireless connectivity, dose safety software and real-time monitoring, which enhances their safety and efficiency. These innovations help reduce medication errors, a significant concern in healthcare.

For instance, in April 2024, Baxter International Inc. cleared the U.S. Food and Drug Administration (FDA) 510(k) clearance of its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. Adding LVP modality to the Novum IQ Infusion Platform, which includes Baxter's syringe infusion pump (SYR) with Dose IQ Safety Software, powered by the IQ Enterprise Connectivity Suite, enables clinicians to utilize a single, integrated system across a variety of patient care settings.

As more patients prefer managing their treatments at home, the need for portable infusion pumps has increased. Smart pumps allow for remote monitoring and data sharing, which are crucial for home healthcare settings, especially for chronic patients requiring ongoing infusion therapy.

Geographical Analysis

North America is expected to hold a significant position in the smart pumps market share

North America is expected to hold the largest market share in the global smart pumps market. North America, especially the United States is home to leading manufacturers of smart pumps, including Medtronic, Baxter International and other emerging players, which are continuously innovating to develop advanced, user-friendly smart pumps. These innovations, such as wireless connectivity, real-time monitoring and cloud-based data analytics, make these devices highly desirable in the healthcare industry.

For instance, in June 2023, B. Braun Medical Inc. launched its next generation of infusion management software, DoseTrac Enterprise Infusion Management Software. With this new software, organizations receive a mix of real-time views and retrospective reporting features to better understand their infusion pump fleet and associated data. The DoseTrac Enterprise Software platform can also connect up to 40,000 pumps at an unlimited number of facilities with just one application.

North America has a high prevalence of chronic diseases like diabetes, heart disease and cancer, which require continuous medication administration via infusion pumps. This has fueled the demand for smart pumps, especially for insulin infusion pumps and chemotherapy drug delivery systems. For instance, according to the American Diabetes Association, 38.4 million Americans, or 11.6% of the population, have diabetes, many of whom rely on infusion pumps for insulin delivery. The growing patient population is a significant driver for the smart infusion pump market.

Asia-Pacific is growing at the fastest pace in the smart pumps market

The Asia-Pacific region is experiencing the fastest growth in the smart pumps market. There has been a rapid increase in the adoption of smart healthcare devices in the Asia Pacific region. This is partly driven by the growing need for remote monitoring, dose error reduction and patient safety in hospitals and home care settings. Major market players in this region especially China, India and Japan focusing on smart infusion pumps with integrated technologies that allow for wireless communication, real-time data sharing and remote patient monitoring are seeing a surge in demand.

For instance, in February 2023 Mindray launched its BeneFusion i Series and u Series infusion systems featuring high precision, adaptive customization and extraordinary simplicity for guaranteed levels of medication safety in a variety of clinical settings. The new generation of smart pumps, for their advanced features to reduce medication errors, streamline workflow and improve cost-effectiveness, has seen greater potential in endoscopic, obstetrics, oncology, emergency departments and more.

Competitive Landscape

The major global players in the smart pumps market include B. Braun Medical Inc., Medtronic plc, Fresenius Kabi USA, LLC, Terumo Corporation, Becton, Dickinson and Company, ICU Medical, Inc., Baxter International Inc., Insulet Corporation, BPL Medical Technologies, SINO MDT and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global smart pumps market report delivers a detailed analysis with 70 key tables, more than 65 visually impactful figures, and 179 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Connectivity
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Demand for Home Healthcare
      • 3.1.1.2. Rising Technological Advancements
    • 3.1.2. Restraints
      • 3.1.2.1. Operational and User Challenges
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging pioneers and prominent players
    • 4.1.2. Established leaders with largest-selling brands
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Smart Pumps Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Infusion Smart Pumps*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Smart Feeding Pumps
  • 5.4. Specialized Pumps

6. Smart Pumps Market, By Connectivity

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 6.1.2. Market Attractiveness Index, By Connectivity
  • 6.2. Standalone Pumps*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Connected Pumps
    • 6.3.1. Wired Connectivity
    • 6.3.2. Wireless Connectivity

7. Smart Pumps Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Drug Delivery*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Chemotherapy
  • 7.4. Pain Management
  • 7.5. Diabetes Management
  • 7.6. Neonatal and Pediatric Care
  • 7.7. Others

8. Smart Pumps Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Specialty Clinics
  • 8.4. Ambulatory Surgical Centers
  • 8.5. Homecare Settings

9. Smart Pumps Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. B. Braun Medical Inc. *
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. Medtronic plc
  • 11.3. Fresenius Kabi USA, LLC
  • 11.4. Terumo Corporation
  • 11.5. Becton, Dickinson and Company
  • 11.6. ICU Medical, Inc.
  • 11.7. Baxter International Inc.
  • 11.8. Insulet Corporation
  • 11.9. BPL Medical Technologies
  • 11.10. SINO MDT (LIST NOT EXHAUSTIVE)

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us